Devgen, Syngenta deal

Syngenta said that as of Feb. 26, 98.32% of agbio company Devgen shares had been tendered. Syngenta said following a "squeeze-out," the results of which will be announced on March 5, it will own 100% of Devgen. Devgen was also delisted from NYSE Euronext Brussels. Last September, Syngenta announced plans to acquire Devgen for €16 per share, or about €403 million ($522.8 million). ...